Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03808883 · ClinicalTrials.gov registry record · NA
TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03808883 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 49 participants.
The verdict
NCT03808883, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Transgender and gender nonconforming (TGNC) individuals face a number of health disparities, many of which can be tied to a lack of access to or use of primary care. Stigma and misunderstanding make simple doctor's visits into ordeals only worth enduring for the most serious of problems. This project addresses those issues by enlisting TGNC people as experts on their own experience. TGNC individuals will form a year-long cohort that will form the basis for this research. Collectively, they will define the scope of challenges faced when seeking healthcare, what medical advocacy training they desire, and how to address groups of healthcare providers and staff. Healthcare providers, including MDs, nurses, and Physicians Assistants (PAs), will attend two facilitated sessions with the TGNC cohort to meet as peers with knowledge exchanged in both directions. Similar meetings will occur with clinic staff, as TGNC individuals have expressed how stigma begins from the moment they call a medical office. Our hypothesis is that when TGNC individuals are given the tools to navigate the healthcare system and the ability to speak with medical professionals as peers, rather than patients, through a participatory action research design they will be better able to access appropriate care through increased confidence and mutual support. The complementary hypothesis for medical providers is that direct interaction with a variety of TGNC individuals who articulate their needs will decrease stigma and increase comfort when treating TGNC people as patients. As a partnership between academic, medical, and community institutions, this project has the potential to directly impact the lives of TGNC individuals who participate and indirectly impact others served by the LGBT Center. This proposal works on three levels: 1) at the academic level - an assessment of participatory action research as an intervention to decrease health disparities, 2) at the individual level - the potential for indivi
Interventions
- BEHAVIORAL TGNC Directed Advocacy Meetings
- BEHAVIORAL Facilitated Dialogues between TGNC Cohort and Healthcare Participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2020-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03808883
The ClinicalTrials.gov registry entry for NCT03808883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TGNC Directed Advocacy Meetings is the first listed.
NCT03808883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03808883 about?
NCT03808883 is a clinical study titled "TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare". Transgender and gender nonconforming (TGNC) individuals face a number of health disparities, many of which can be tied to a lack of access to or use of primary care. Stigma and misunderstanding make simple doctor's visits into ordeals only worth enduring for the most serious of problems. This projec...
What is the current status of trial NCT03808883?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2019-02-01. Estimated completion is 2020-12-10.
What interventions are being tested in trial NCT03808883?
The interventions under investigation include: TGNC Directed Advocacy Meetings (BEHAVIORAL), Facilitated Dialogues between TGNC Cohort and Healthcare Participants (BEHAVIORAL).
Who is sponsoring clinical trial NCT03808883?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.